Nathan Connell: Why Prophylaxis in vWD Has Historically Lagged Behind Established Practice in Hemophilia
Nathan Connell, Clinical Chief of Hematology at Brigham and Women’s Faulkner Hospital, shared a post on Linkedln about a recent article he and his colleagues co-authored, adding:
“I’m pleased to share our recent paper, ‘Prophylaxis for von Willebrand disease: Is it time for parity with established practice in hemophilia A?’ published in Therapeutic Advances in Hematology.
It was a privilege to work on this with Robert Sidonio, Fernando Corrales-Medina, Jill Johnsen, Michelle Sholzberg, and Caroline Malcolmson.
In this review, we examine why prophylaxis in von Willebrand disease has historically lagged behind established practice in hemophilia, despite a substantial bleeding burden in patients with severe and recurrent disease.
We discuss barriers to broader implementation, review emerging clinical evidence supporting prophylactic VWF replacement, and argue that the field is moving toward a more individualized, phenotype-driven approach that may help bring VWD care closer to parity with hemophilia.
Recent prospective data and regulatory progress suggest that prophylaxis should be considered more systematically for appropriately selected patients.
Thank you to Octapharma for supporting the medical writing assistance for this publication.”
Title: Prophylaxis for von Willebrand disease: Is it time for parity with established practice in hemophilia A?
Authors: Robert F. Sidonio Jr., Fernando F. Corrales-Medina, Jill M. Johnsen, Michelle Sholzberg, Caroline Malcolmson, Nathan T. Connell
Read the Full Article on Therapeutic Advances in Hematology
Other posts featuring Nathan Connell on Hemostasis Today.
-
Sep 19, 2026, 14:17Abdul Mannan: What Exactly Is a Platelet?
-
Sep 19, 2026, 13:39Keisuke Goda: Decoding Platelet Phenotypes in COVID-19 With Optofluidic Imaging
-
Sep 19, 2026, 13:30Targeted Thrombolysis Beyond tPA
-
Sep 19, 2026, 13:21Paul Armstrong: From Summer Studentship to Young Researcher
-
Sep 19, 2026, 13:06Rabiya Masood: Breaking the Cycle of Thalassemia Through Screening
-
Sep 19, 2026, 10:52Consuela A. Albright: The Critical Role of Black Blood Donors in Sickle Cell Treatment
-
Sep 19, 2026, 10:47Amber Yates: Inside Agios’ Partnership with the Sickle Cell Community
-
Sep 19, 2026, 10:46Anton Farkas: Mechanical Thrombectomy for Acute PE in Early Pregnancy
-
Sep 19, 2026, 10:40Marjolein Smidt: ASH Raises Ferritin Thresholds for Iron Deficiency